Skip to main content
Premium Trial:

Request an Annual Quote

Genedata, ChemAxon Integrate Lead Discovery Software

NEW YORK (GenomeWeb News) - Genedata has integrated its lead-discovery software with ChemAxon’s chemical visualization technology, Genedata said today.
 
The integration will join Genedata’s Hit Profiler software with ChemAxon’s MarinView, and will be used in identifying novel drug candidates.
 
MarinView is used for visualizing and managing chemical structure information, Genedata said, adding that the integration allows the companies to “evolve their solutions independently, yet maintain interoperability.”

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.